Effect and safety of immune checkpoint inhibitors for brain metastases from non-small cell lung cancer

被引：0
|
作者：
Iuchi, T. [1 ]
Ashinuma, H. [2 ]
Yoshida, Y. [2 ]
Mizuno, S. [2 ]
Hosono, J. [1 ]
Setoguchi, T. [1 ]
Hasegawa, Y. [1 ]
Sakaida, T. [1 ]
Shingyoji, M. [2 ]
机构：
[1] Chiba Canc Ctr Hosp, Dept Neurol Surg, Chiba, Japan
[2] Chiba Canc Ctr Hosp, Respirol Dept, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1516P
引用
收藏
页码：622 / 622
页数：1
相关论文
共 50 条
  • [31] The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
    Luo, Lumeng
    Liu, Peiyi
    Zhao, Kuaile
    Zhao, Weixin
    Zhang, Xiaofei
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Qiu, Zhenbin
    Chen, Zihao
    Zhang, Chao
    Zhong, Wenzhao
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [33] Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Soh, Junichi
    Hamada, Akira
    Fujino, Toshio
    Mitsudomi, Tetsuya
    [J]. CANCERS, 2021, 13 (16)
  • [34] Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer
    Bote, Helena
    Mesas, Andres
    Baena, Javier
    Herrera, Mercedes
    Paz-Ares, Luis
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) : 289 - 300
  • [35] Immune Checkpoint Inhibitors in Oncogenic Driven Non-small Cell Lung Cancer
    Fonseca, A.
    Silva, E.
    Coutinho, D.
    Campainha, S.
    Dias, M.
    Barroso, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S339 - S340
  • [36] Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Ushio, Ryota
    Murakami, Shuji
    Saito, Haruhiro
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [37] Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Jung, Chi Young
    Antonia, Scott J.
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2018, 81 (01) : 29 - 41
  • [38] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    [J]. THORACIC CANCER, 2024, 15 (05) : 419 - 426
  • [39] Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer
    Cunha, R.
    Fernandes, M.
    Abreu, S.
    Oliveira, C.
    Dias, J.
    Alves, S.
    Rodrigues, A.
    Oliveira, J.
    Pousa, M. I.
    Soares, M.
    Azevedo, I.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1432 - S1432
  • [40] Safety of Palliative Radiotherapy and Immune Checkpoint Inhibitors in Patients with Metastatic Non-Small Cell Lung Cancer
    Tjong, M.
    Ragulojan, M.
    Poon, I.
    Cheng, S.
    Doherty, M.
    Ung, Y.
    Cheung, P.
    Cheema, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S667 - S668
12345